[ad_1]
PHOTO: Pixabay
Researchers in the US have found that inhaled vaccines elicit a strong and rapid immune response in experiments with mice and primates, without causing lung damage, Medical Express reported.
The results of the study were published in the journal Med. They note that a safe and effective system for introducing vaccines into the lungs could be used for immunizations and treatment of respiratory diseases, BTA reported.
“This implementation strategy has the potential to make vaccines and therapies more effective, while reducing the likelihood of toxic side effects,” said study co-author Wadih Arap of the Rutgers Cancer Research Institute in New Jersey.
“We hope this will play a key role in the development of vaccines and treatments to block the spread of respiratory infectious diseases, possibly for the current Covid-19 pandemic, especially among people with limited access to healthcare,” he added.
Pulmonary administration has many advantages over other forms of administration because the therapy or vaccine reaches the target directly.
It can be used to protect against airborne pathogens that cause diseases such as tuberculosis, influenza, Ebola, measles, and others.
[ad_2]
